Dr. Mark Lambrecht is Global Head of Health Care and Life Sciences Advisory at SAS. He and his team operate on the intersection of research, information science and analytical cloud technology to solve advanced analytical and AI challenges at hospitals, pharmaceutical manufacturers and various health care organisations. Prior to joining SAS, he worked in the pharmaceutical industry and obtained a Masters and PhD in Applied Bioscience Engineering, Cell- and Gene Technology at the University of Leuven (Belgium) and conducted Postdoctoral Research at Stanford University (USA).
Clinical trials are the engine behind every new treatment we see – from life-saving cancer drugs to vaccines that help us fight global pandemics. But behind the scenes, running these trials involves juggling massive amounts of complex, sensitive data. For pharmaceutical companies, outdated technology systems can slow everything down, delaying
As in most other sectors, health care is changing at lightning speed. Access to data makes it possible to speed up clinical trials, develop more personalized medication, make quicker and better diagnoses, improve the quality of patient care and save lives. The pandemic has sped up digital transformation in every
Geen sector die de afgelopen twee jaar zo hard onder druk stond als de gezondheidszorg. En ook nu het einde van de pandemie in zicht lijkt, zullen veel uitdagingen rond Healthcare en Life Sciences niet verdwijnen. Gelukkig investeren zowel overheden als ziekenhuizen en farmaceutische bedrijven fors in data en analytics
